期刊文献+

急性心肌梗死发病季节和时间规律及其与树突状细胞功能的关系 被引量:3

Circadian and seasonal variations in the incidence of acute myocardial infarction and their relation to functions of dendritic cells
原文传递
导出
摘要 目的:了解急性心肌梗死(AMI)的季节性和日内时间性发病规律,探讨其与循环树突状细胞功能的关系。方法:收集272例AMI住院病例,对不同季节(分1~3月,4~6月,7~9月和10~12月4季)和日内时间段(分0∶01~6∶00,6∶01~12∶00,12∶01~18∶00、18∶01~24∶004个时段)的发病率进行比较和统计;检测血循环树突状细胞的功能。结果:AMI患者1~3月和10~12月发病率明显高于4~6月和7~9月,P〈0.01)。日内发病率以6∶01~12∶00明显高于其他时间段(P〈0.01)。患者和正常对照组循环树突状细胞的功能亦呈明显的季节和日内时间规律。AMI的季节和日内发病比例变化与树突状细胞的功能变化高度相关。结论:AMI的发病率有冬春季明显高于夏秋季、日内以6∶01~12∶00明显高于其他时间段的规律特征,树突状细胞介导的免疫炎症反应可能是这一规律的机制之一。 Objective: To determine the circadian and seasonal variations in the incidence of acute myocardial infarction (AMI) and evaluate the relationship between dendritic cells(DCs) and them. Method: A total of 272 consecutive patients with AMI was analyzed. The incidence of AMI at six--hour intervals over 24 hours (4 periods) and four-month intervals in a year (4 seasons) were studied respectively. The function of DCs from the AMI patients and the healthy controls was determined. Result: The incidence of AMI in the period from January to March and from October to December was higher than those from April to June and from July to September. We also found that there was a circadian variation in the onset of AMI with a morning peak (6 am to 12 am). Function of DCs revealed circadian and seasonal variation in both healthy controls and the AMI patients. The circadian and seasonal variation in incidence of AMI was correlated with the function of DCs. Conclusion: The incidence of AMI is higher in Winter and Spring than in Summer and Autumn with a morning peak from 6 am to 12 am. Immuno-inflammatory reaction mediated by DCs might play an important role in the circadian and seasonal variations of AMI.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2008年第9期659-661,共3页 Journal of Clinical Cardiology
关键词 心肌梗死 季节 炎症 树突状细胞 Myocardial infarction Seasons Inflammation Dendritic cell
  • 相关文献

参考文献7

  • 1MANFREDINI R, BOARI B, SMOLENSKY M H, et al. Seasonal variation in onset of myocardial infarction--a 7-year single-center study in Italy[J]. Chronobiol Int, 2005, 22 :1121--1135.
  • 2SHAH P K. Mechanism of plaque vulnerability and rupture[J].JACC, 2003, 41: S8--S14.
  • 3李大主,Sharma Ranjit,曾秋棠,田园,冯义柏,王祥,曹林生.阿托伐他汀对不稳定型心绞痛患者树突状细胞功能的影响[J].中华内科杂志,2004,43(6):429-432. 被引量:21
  • 4MAVRI A, GUZIC-SALOBIR B, SALOBIR-PAJNIC B, et al. Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease[J]. Blood Coagul Fibrinolysis, 2001, 12:359--365.
  • 5DIMITROV S, LANG T, NOHROUDI K, et al. Number and function of circulating human antigen presenting cells regulated by sleep[J]. Sleep, 2007, 30:401--411.
  • 6MYRIANTHEFS P, KARATZAS S, VENETSANOU K, et al. Seasonal variation in whole blood cy tokine production after LPS stimulation in normal in dividuals[J]. Cytokines,2003,24:286--292.
  • 7NAHMOD K A, VERMEULEN M E, RAIDEN S, et al. Control of dendritic cell differentiation by angiotensin II[J].FASEB J, 2003,17: 491--493.

二级参考文献10

  • 1Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol,2003,41(4 Suppl S):15S-22S.
  • 2Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart, 2002,87:201-204.
  • 3Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998,392:245-252.
  • 4Lefer DJ. Statins as potent antiinflammatory drugs. Circulation,2002,106:2041-2042.
  • 5Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res,2002,91:281-291.
  • 6Bobryshev YV, Lord RS. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res, 1995,29:689-696.
  • 7Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation, 1999,99:855-860.
  • 8Alderman CJ, Bunyard PR, Chain BM, et al. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res, 2002,55:806-819.
  • 9Kinlay S, Schwartz GG, Olsson AG, et al. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation, 2003,108:1560-1566.
  • 10Correia LC, Sposito AC, Lima JC, et al. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. Am J Cardiol,2003,92:298-301.

共引文献20

同被引文献21

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部